1. Home
  2. AGRZ vs APM Comparison

AGRZ vs APM Comparison

Compare AGRZ & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGRZ

Agroz Inc. Ordinary Shares

HOLD

Current Price

$0.29

Market Cap

6.3M

ML Signal

HOLD

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$0.86

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGRZ
APM
Founded
2020
2010
Country
Malaysia
United Kingdom
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
7.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AGRZ
APM
Price
$0.29
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
242.2K
219.0K
Earning Date
05-11-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.65
52 Week High
$7.20
$4.47

Technical Indicators

Market Signals
Indicator
AGRZ
APM
Relative Strength Index (RSI) 41.45 45.60
Support Level N/A $0.74
Resistance Level $0.40 $0.98
Average True Range (ATR) 0.04 0.17
MACD -0.00 0.01
Stochastic Oscillator 47.58 12.59

Price Performance

Historical Comparison
AGRZ
APM

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.

Share on Social Networks: